Trials / Completed
CompletedNCT01572675
A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)
Pharmacoepidemiological Study on the Use of Arcoxia® Under Actual Conditions of Use in France
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 547 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This postmarketing study will examine the use of etoricoxib (Arcoxia®) in routine clinical practice in France as well as the use of celecoxib (Celebrex®).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etorocoxib | Administered as 30 mg or 60 mg oral film-coated tablets |
| DRUG | celecoxib | Administered as 100 mg or 200 mg oral hard capsules |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2012-04-06
- Last updated
- 2022-02-09
- Results posted
- 2016-05-25
Source: ClinicalTrials.gov record NCT01572675. Inclusion in this directory is not an endorsement.